Scholarlink

<p>CD8<sup>+</sup> T cells are an important weapon in the therapeutic armamentarium against cancer. While CD8<sup>+</sup>CD103<sup>+</sup> T cells with a tissue-resident memory T (T<sub>RM</sub>) cell phenotype are associated with favorable prognoses, the tumor microenvironment also contains dysfunctional exhausted T (T<sub>EX</sub>) cells that exhibit a variety of T<sub>RM</sub>-like features. Here we deconvolute T<sub>RM</sub> and T<sub>EX</sub> cells across human cancers, ascribing markers and gene signatures that distinguish these populations and enable their functional distinction. Although T<sub>RM</sub> cells have superior functionality and are associated with long-term survival post-tumor resection, they are not associated with responsiveness to immune checkpoint blockade. Tumor-associated T<sub>EX</sub> and T<sub>RM</sub> cells are clonally distinct, with the latter comprising tumor-independent bystanders and tumor-specific cells segregated from cognate antigen. Intratumoral T<sub>RM</sub> cells can be forced toward an exhausted fate when chronic antigen stimulation occurs, indicating that the presence or absence of continuous antigen exposure within the microenvironment is the key distinction between tumor-associated T<sub>EX</sub> and T<sub>RM</sub> populations. These results highlight unique functions for T<sub>RM</sub> and T<sub>EX</sub> cells in tumor control, underscoring the need for distinct strategies to harness these populations for cancer therapies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月29日

查看全文
  • Thomas N. Burn,
  • Jan Schröder,
  • Luke C. Gandolfo,
  • Maleika Osman,
  • Elanor N. Wainwright,
  • Enid Y. N. Lam,
  • Keely M. McDonald,
  • Rachel B. Evans,
  • Shihan Li,
  • Daniel Rawlinson,
  • Lachlan Dryburgh,
  • Ali Zaid,
  • Zoltan Maliga,
  • Dominick Schienstock,
  • Philippa Meiser,
  • Hyun Jae Lee,
  • Hongjin Lai,
  • Marcela L. Moreira,
  • Pirooz Zareie,
  • Louis H-Y. Lee,
  • Lutfi Huq,
  • Susan N. Christo,
  • Justine J. W. Seow,
  • Keith A. Ching,
  • Stéphane M. Guillaume,
  • Kathy Knezevic,
  • Simone L. Park,
  • Maximilien Evrard,
  • Jason Waithman,
  • Thomas Gebhardt,
  • Scott N. Mueller,
  • Georgina E. Riddiough,
  • Marcos V. Perini,
  • Simon C. H. Tsao,
  • Terence P. Speed,
  • Peter K. Sorger,
  • Sherene Loi,
  • Francis R. Carbone,
  • Stephanie Gras,
  • Timothy S. Fisher,
  • Bas J. Baaten,
  • Mark A. Dawson,
  • Laura K. Mackay

摘要

CD8+ T cells are an important weapon in the therapeutic armamentarium against cancer. While CD8+CD103+ T cells with a tissue-resident memory T (TRM) cell phenotype are associated with favorable prognoses, the tumor microenvironment also contains dysfunctional exhausted T (TEX) cells that exhibit a variety of TRM-like features. Here we deconvolute TRM and TEX cells across human cancers, ascribing markers and gene signatures that distinguish these populations and enable their functional distinction. Although TRM cells have superior functionality and are associated with long-term survival post-tumor resection, they are not associated with responsiveness to immune checkpoint blockade. Tumor-associated TEX and TRM cells are clonally distinct, with the latter comprising tumor-independent bystanders and tumor-specific cells segregated from cognate antigen. Intratumoral TRM cells can be forced toward an exhausted fate when chronic antigen stimulation occurs, indicating that the presence or absence of continuous antigen exposure within the microenvironment is the key distinction between tumor-associated TEX and TRM populations. These results highlight unique functions for TRM and TEX cells in tumor control, underscoring the need for distinct strategies to harness these populations for cancer therapies.